ETFIQData as of Nov 18, 2026. · etfiq.com/funds/nvoh

NVOH Fact Sheet: Novo Nordisk A/S (B Shares) ADRhedged

Share
$22.73
close, Nov 18, 2026

Over the year to Nov 18, 2026, NVOH returned −8.1% in total and charged 0.19% a year.

1-year total return
−8.1%
to Nov 18, 2026
Expense ratio
0.19%
a year
Net flow, 12 months to Jun 30, 2026
+$4.1m
monthly N-PORT basis to Jun 30, 2026

Growth of $10,000, 1 year

NVOH $9,192 −8.1% · VOO $11,188 +11.9% · Total return, distributions reinvested, Nov 18, 2025 to Nov 18, 2026.

Returns

WindowTotal return
1 month+4.9%
3 months−9.1%
Year to date−13.2%
1 year−8.1%
Since launch−50.5%

Total return, distributions reinvested, each window to Nov 18, 2026.

Facts

Equity fund · Actively managed · First traded Jan 7, 2025 · Benchmark Its own holdings, as of Jun 30, 2026

Source: ETFIQ, from issuer disclosures, SEC filings and exchange prices. Returns from daily closes, distributions reinvested; each number is dated beside it, and every one is on the fund’s page.Cite as: ETFIQ, NVOH Fact Sheet: Novo Nordisk A/S (B Shares) ADRhedged. Data as of Nov 18, 2026. https://etfiq.com/funds/nvoh/fact-sheet/ETFIQ is an independent publisher. Not an issuer, broker or adviser. No recommendations. Printed from etfiq.com/funds/nvoh.